Skip to contentH
Haemonetics Corp
H
HAEHaemonetics Corp Q3 2016 · 10-Q
Revenue$233.38M$233.38M+0.7% vs Q3 2015 Net Income-$59.44M-$59.44MN/M vs Q3 2015 EPS Diluted-$1.17-$1.17N/M vs Q3 2015 Gross Profit$108,855,000−2.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Haemonetics Corp · CIK 313143 · Engraved from SEC EDGAR
Operating Cash Flowderived$31,851,000+18.4% Free Cash Flowderived$8,110,000N/M Margins · derivedGross margin46.6%−1.5 pt vs Q3 2015
Operating margin-26.2%−34.1 pt vs Q3 2015
Net margin-25.5%−32.4 pt vs Q3 2015
ended Dec 26, 2015 · filed Feb 2, 2016 · 38 d after period end